Cubic Pharmaceuticals Ltd (here after referred as ‘Cubic’) was established in June 2008 and Cubi-Tech extrusion Ltd (here after referred as Cubi-tech) was established in 2018 as a sister company of Cubic.
Cubic has developed Quality Management System for pharmaceutical products and obtained.
MIA (manufacturer’s and importer’s authorisation) and wholesale dealer license for human medicinal products from MHRA (MIA 33846 & WDA (H) 33846).
The Quality management system is same for both Cubic pharmaceutical and Cubi-tech extrusion.
Cubi-Tech is a manufacturing and testing organisation, with the ISO class 8 clean rooms and outfitted with a well-equipped tablet development lab and a complete hot-melt extrusion line.
The Cubi-Tech extrusion Ltd, has ISO 9001:2015 approval with scope of certification for the manufacturing of nutraceuticals or food supplements.
The future vision of the management is to extend the business to CDMO/ manufacture investigational medicinal products operations at Cubi-Tech extrusion Ltd, extending the scope of license approval’s to MHRA GMP/ MIA (IMP) license and ISO 9001:2015.
Cubi-Tech extrusion Ltd, is committed to doing our part in improving the health and lives of the public through the development of innovative drug products, optimisation of manufacturing process of pharmaceuticals and though offering advanced characterisation techniques to our customers and partners.
Cubi-Tech mission is to provide advanced insights into drug development and formulation through advanced API screening, economical manufacturing process and thorough Physiochemical characterisation in order to develop safe and effective dosage forms.
Cubi-Tech employs renown experts in tableting and extrusion technologies to ensure your products are produced the most efficient, cost-effective, safest, environmentally friendly and overall economical manner possible.
Cubi-Tech has a number of computational and experimental techniques to allow for thorough drug screening at its disposal, as well as a pedigree in identifying suitable multi-component systems, to suit our customer’s needs.
With our staffs’ expertise and knowledge, Cubi-Tech can provide a range of preformulating services to identify suitable techniques to enhance a range of properties of our customers API.
Cubi-Tech is also outfitted with an advanced material characterisation lab, equipped with a wide array of analytical equipment to help discover everything there is to know about your molecules.
Led by our experienced team and collaborative approach, our analytical services compliment our proficiency in drug development and manufacturing to provide the most efficient path to success for our customers.
Cubi-Tech is equipped with a range of physical, chemical, dissolution, stability and microbiological testing equipment to allow us to discover every necessary detail about a molecule to suit our customers formulation, development and validation needs.
It is through these areas that we believe Cubi-Tech can do our part in providing our customers and the greater medical community with the most efficient part to success and contribute to a healthier and happier world.